Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label phase 2 trial of imatinib in desmoid tumor and chondrosarcoma
2006-006446-33Phase 2Completed
- Sponsor
- Italian Sarcoma Group
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of imatinib in aggressive fibromatosis (AF), chondrosarcoma and Bone and soft tissue sarcoma (2 arms), sponsored by Italian Sarcoma Group. Primary endpoint: Overall response rate. Started Nov 2007; status: completed.
02
Drugs
03
Conditions
aggressive fibromatosis (AF)chondrosarcomaBone and soft tissue sarcoma
Beyond the preview
Go deeper on 2006-006446-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006446-33.